Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer

Clinical trial NCT03951415 · UNKNOWN

Trial details

NCT number: NCT03951415
Sponsor: Leiden University Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Neoplasms Uterine Neoplasms Endometrium Cancer

Start date: 2019-07-08
Primary completion: 2021-08-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.